Page last updated: 2024-09-05

sorafenib and stx-0119

sorafenib has been researched along with stx-0119 in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(stx-0119)
Trials
(stx-0119)
Recent Studies (post-2010) (stx-0119)
6,5207305,25122020

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Asai, A; Asakawa, N; Hirata, G; Kurita, A; Nishisaka, F; Ogo, N; Shishido, Y; Takagi, A; Takahashi, H; Taniguchi, K; Tsugane, M1

Other Studies

1 other study(ies) available for sorafenib and stx-0119

ArticleYear
Antitumor activity of a novel oral signal transducer and activator of transcription 3 inhibitor YHO-1701.
    Cancer science, 2020, Volume: 111, Issue:5

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Therapy, Combination; Humans; Interleukin-6; Mice; Molecular Docking Simulation; Mouth Neoplasms; Oxadiazoles; Protein Multimerization; Quinolines; Signal Transduction; Sorafenib; src Homology Domains; STAT3 Transcription Factor; Survivin; Xenograft Model Antitumor Assays

2020